Second Open Label Extension to Bridging Study CTBM100C2303

Mise à jour : Il y a 4 ans
Référence : NCT01069705

Femme et Homme

Extrait

This is an open-label, single arm (uncontrolled) study in patients suffering from cystic fibrosis, who have completed their study participation in CTBM100C2303 and extension study one CTBM100C2303E1 (all visits), who were proven infected with Pseudomonas aeruginosa at enrollment into CTBM100C2303.


Critère d'inclusion

  • Pulmonary Infections ,Pseudomonas Aeruginosa


Liens